@article{ART002175914},
author={nara Han and 심우문 and 설무창 and 김민철 and 이창희 and 김동원 and 이세훈 and 이호철 and 류중민 and 남봉수 and 김종옥 and 문성오 and 장현록 and kim,young-suk and In Lee and 양진영 and 황규선 and 천창선 and 정현석},
title={Genuine traditional Korean medicine, BaekJeol-Tang for the treatment of rheumatoid arthritis},
journal={CELLMED},
issn={3022-6805},
year={2013},
volume={3},
number={2},
pages={18-18}
TY - JOUR
AU - nara Han
AU - 심우문
AU - 설무창
AU - 김민철
AU - 이창희
AU - 김동원
AU - 이세훈
AU - 이호철
AU - 류중민
AU - 남봉수
AU - 김종옥
AU - 문성오
AU - 장현록
AU - kim,young-suk
AU - In Lee
AU - 양진영
AU - 황규선
AU - 천창선
AU - 정현석
TI - Genuine traditional Korean medicine, BaekJeol-Tang for the treatment of rheumatoid arthritis
JO - CELLMED
PY - 2013
VL - 3
IS - 2
PB - Cellmed Orthocellular Medicine and Pharmaceutical Association
SP - 18
EP - 18
SN - 3022-6805
AB - Inflammation in rheumatoid arthritis is characterized by immune cell infiltration and cytokine secretion. In particular, mast cells and their cytokines play an important role in the pathogenesis of rheumatoid arthritis. Korean medicine, BaekJeol-Tang (BT) was designed by traditional Korean medicine theory. We already reported therapeutic effect of BT in rheumatoid arthritis. Here, we report the specific underlying mechanism of BT in activated human mast cells, HMC-1 cells. In addition, we report for the first time that BT significantly inhibited the production and mRNA expression of proinflammatory cytokines including thymic stromal lymphopoietin, interleukin (IL)-1β, IL-6, IL-8, and tumor necrosis factor-α in activated HMC-1 cells. BT also decreased the activation of mitogen-activated protein kinases, nuclear factor-κB, and caspapase-1. Taken together, these results indicate that BT has potential as a regulator of inflammatory reactions for the treatment of arthritis such as osteoarthritis and rheumatoid arthritis.
KW - rheumatoid arthritis;BaekJeol-Tang;mast cells;caspase-1;thymic stromal lymphopoietin;ostheoarthritis
DO -
UR -
ER -
nara Han, 심우문, 설무창, 김민철, 이창희, 김동원, 이세훈, 이호철, 류중민, 남봉수, 김종옥, 문성오, 장현록, kim,young-suk, In Lee, 양진영, 황규선, 천창선 and 정현석. (2013). Genuine traditional Korean medicine, BaekJeol-Tang for the treatment of rheumatoid arthritis. CELLMED, 3(2), 18-18.
nara Han, 심우문, 설무창, 김민철, 이창희, 김동원, 이세훈, 이호철, 류중민, 남봉수, 김종옥, 문성오, 장현록, kim,young-suk, In Lee, 양진영, 황규선, 천창선 and 정현석. 2013, "Genuine traditional Korean medicine, BaekJeol-Tang for the treatment of rheumatoid arthritis", CELLMED, vol.3, no.2 pp.18-18.
nara Han, 심우문, 설무창, 김민철, 이창희, 김동원, 이세훈, 이호철, 류중민, 남봉수, 김종옥, 문성오, 장현록, kim,young-suk, In Lee, 양진영, 황규선, 천창선, 정현석 "Genuine traditional Korean medicine, BaekJeol-Tang for the treatment of rheumatoid arthritis" CELLMED 3.2 pp.18-18 (2013) : 18.
nara Han, 심우문, 설무창, 김민철, 이창희, 김동원, 이세훈, 이호철, 류중민, 남봉수, 김종옥, 문성오, 장현록, kim,young-suk, In Lee, 양진영, 황규선, 천창선, 정현석. Genuine traditional Korean medicine, BaekJeol-Tang for the treatment of rheumatoid arthritis. 2013; 3(2), 18-18.
nara Han, 심우문, 설무창, 김민철, 이창희, 김동원, 이세훈, 이호철, 류중민, 남봉수, 김종옥, 문성오, 장현록, kim,young-suk, In Lee, 양진영, 황규선, 천창선 and 정현석. "Genuine traditional Korean medicine, BaekJeol-Tang for the treatment of rheumatoid arthritis" CELLMED 3, no.2 (2013) : 18-18.
nara Han; 심우문; 설무창; 김민철; 이창희; 김동원; 이세훈; 이호철; 류중민; 남봉수; 김종옥; 문성오; 장현록; kim,young-suk; In Lee; 양진영; 황규선; 천창선; 정현석. Genuine traditional Korean medicine, BaekJeol-Tang for the treatment of rheumatoid arthritis. CELLMED, 3(2), 18-18.
nara Han; 심우문; 설무창; 김민철; 이창희; 김동원; 이세훈; 이호철; 류중민; 남봉수; 김종옥; 문성오; 장현록; kim,young-suk; In Lee; 양진영; 황규선; 천창선; 정현석. Genuine traditional Korean medicine, BaekJeol-Tang for the treatment of rheumatoid arthritis. CELLMED. 2013; 3(2) 18-18.
nara Han, 심우문, 설무창, 김민철, 이창희, 김동원, 이세훈, 이호철, 류중민, 남봉수, 김종옥, 문성오, 장현록, kim,young-suk, In Lee, 양진영, 황규선, 천창선, 정현석. Genuine traditional Korean medicine, BaekJeol-Tang for the treatment of rheumatoid arthritis. 2013; 3(2), 18-18.
nara Han, 심우문, 설무창, 김민철, 이창희, 김동원, 이세훈, 이호철, 류중민, 남봉수, 김종옥, 문성오, 장현록, kim,young-suk, In Lee, 양진영, 황규선, 천창선 and 정현석. "Genuine traditional Korean medicine, BaekJeol-Tang for the treatment of rheumatoid arthritis" CELLMED 3, no.2 (2013) : 18-18.